Does CERITINIB Cause Neurological decompensation? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Neurological decompensation have been filed in association with CERITINIB (ZYKADIA). This represents 0.3% of all adverse event reports for CERITINIB.
7
Reports of Neurological decompensation with CERITINIB
0.3%
of all CERITINIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Neurological decompensation From CERITINIB?
Of the 7 reports, 1 (14.3%) resulted in death, 6 (85.7%) required hospitalization, and 3 (42.9%) were considered life-threatening.
Is Neurological decompensation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERITINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CERITINIB Cause?
Malignant neoplasm progression (523)
Diarrhoea (452)
Death (391)
Nausea (381)
Vomiting (270)
Metastases to central nervous system (203)
Non-small cell lung cancer (183)
Fatigue (149)
Decreased appetite (139)
Dyspnoea (137)
What Other Drugs Cause Neurological decompensation?
ALTEPLASE (168)
RITUXIMAB (115)
METHOTREXATE (93)
CYCLOPHOSPHAMIDE (91)
VINCRISTINE (76)
ETOPOSIDE (74)
METHYLPREDNISOLONE (70)
PREDNISONE (70)
DOXORUBICIN (68)
ACETAMINOPHEN (65)
Which CERITINIB Alternatives Have Lower Neurological decompensation Risk?
CERITINIB vs CERLIPONASE ALFA
CERITINIB vs CERTICAN
CERITINIB vs CERTOLIZUMAB
CERITINIB vs CERTOLIZUMAB PEGOL
CERITINIB vs CERTOPARIN